サンプル依頼リスト カート
  • English
  • Korean
表紙：細菌性疾患診断の世界市場 (～2033年)：タイプ・製品・技術・エンドユーザー別の規模・予測・地域別展望・競合戦略
市場調査レポート
商品コード
1351344

細菌性疾患診断の世界市場 (～2033年)：タイプ・製品・技術・エンドユーザー別の規模・予測・地域別展望・競合戦略

Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
出版日: | 発行: SPER Market Research Pvt. Ltd. | ページ情報: 英文 221 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
細菌性疾患診断の世界市場 (～2033年)：タイプ・製品・技術・エンドユーザー別の規模・予測・地域別展望・競合戦略
出版日: 2023年09月11日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 221 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

細菌性疾患診断の市場規模は6.5%のCAGRで成長すると予測されています。

細菌にはいくつかの種類があります。大部分は体に良いものであり、一部が伝染性のもので、病原体とは感染症の原因となるすべての細菌のことをいいます。 抗生物質の無駄な使用を防ぎ、適切な治療を行うためには、細菌感染の正確な診断が不可欠です。細菌感染を確認するためには、炎症や全身機能障害だけでなく、細菌の存在も関係するため、通常、複数の診断法が必要となります。

さらに、COVID-19の原因となった新しいコロナウイルスは、ラボによる検査手順の迅速化に向けた各国政府からサポートを呼び起こしました。パンデミックにより、いくつかの産業では収益が減少しましたが、COVID-19検査への適用が感染症診断の市場を助け、規制当局によるCOVID-19診断製品の認可が早まりました。

当レポートでは、世界の細菌性疾患診断の市場を調査し、市場概要、市場影響因子および市場機会の分析、市場規模の推移・予測、タイプ・製品・地域など各種区分別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因・抑制要因・機会・課題の分析
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • COVID-19による世界の細菌性疾患診断市場への影響

第5章 市場変数と見通し

  • SWOT分析
  • PESTEL分析
  • ポーターのファイブフォース分析
  • ヒートマップ分析

第6章 競合情勢

  • 製造拠点の分布・販売エリア・製品タイプ
  • M&A・提携・製品発売・協力

第7章 世界の細菌性疾患診断市場：タイプ別

  • 市場規模のシェア・予測
  • 細菌性皮膚感染症
  • 食中毒
  • 性感染症

第8章 世界の細菌性疾患診断市場：製品別

  • 市場規模のシェア・予測
  • 消耗品
  • 機器

第9章 世界の細菌性疾患診断市場：技術別

  • 市場規模のシェア・予測
  • DNAマイクロアレイ
  • 免疫診断
  • 等温核酸増幅技術
  • ポリメラーゼ連鎖反応

第10章 世界の細菌性疾患診断市場：エンドユーザー別

  • 市場規模のシェア・予測
  • 病院
  • ラボ
  • 研究センター

第11章 世界の細菌性疾患診断市場の予測

  • 市場規模・市場シェア

第12章 世界の細菌性疾患診断市場：タイプ別

  • 市場規模・市場シェア

第13章 世界の細菌性疾患診断市場：製品別

  • 市場規模・市場シェア

第14章 世界の細菌性疾患診断市場：技術別

  • 市場規模・市場シェア

第15章 世界の細菌性疾患診断市場：エンドユーザー別

  • 市場規模・市場シェア

第16章 世界の細菌性疾患診断市場：地域別

  • 市場規模・市場シェア
  • アジア太平洋
  • 欧州
  • 中東・アフリカ
  • 北米
  • ラテンアメリカ

第17章 企業プロファイル

  • Abbott Laboratories
  • Accelerate Diagnostics Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • Bruker Corp.
  • Danaher Corp
  • DiaSorin SpA
  • EKF Diagnostics Holdings Plc
  • F. Hoffmann La Roche Ltd.
  • GENERI BIOTECH s.r.o.
  • Great Basin Scientific
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Perkin Elmer Inc.
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Siemens AG
  • T2 Biosystems Inc.
  • Takara Bio Inc.
  • その他

第18章 略語リスト

第19章 リファレンスリンク

第20章 総論

第21章 調査範囲

目次
Product Code: HLCA2357

Introduction and Overview

According to SPER Market Research, 'Bacterial Disease Diagnostics Market Size- By Type, By Product, By Technology, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Bacterial Disease Diagnostics Market is predicted to reach with a CAGR of 6.5%.

The several forms of bacteria. However, the majority of them are good for the body while some of them are contagious. Pathogens include all bacteria that are responsible for infectious diseases. To prevent the needless use of antibiotics and to target the right therapy, an accurate diagnosis of bacterial infection is essential. In order to confirm a bacterial infection, more than one diagnostic method is typically needed because it involves the presence of germs as well as inflammation or systemic dysfunction.

Furthermore, the new coronavirus that causes COVID-19 has sparked support from governments all over the world for laboratories to expedite testing procedures. Although the pandemic reduced revenues in several industries, its application in COVID-19 testing helped the market for infectious illness diagnostics. The regulatory authorities hastened the licencing of COVID-19 diagnostic products.

Scope of the Report

Report Metric Details:

  • Market size available for years: 2019-2033
  • Base year considered: 2022
  • Forecast period: 2023-2033
  • Segments covered: By Type, By Product, By Technology, By End User
  • Regions covered: North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
  • Companies Covered: Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., Meridian Bioscience Inc., Perkin Elmer Inc., Quest Diagnostics Inc., and Takara Bio Inc., Others

Market Segmentation:

  • By Type: Based on the Type, Global Bacterial Disease Diagnostics Market is segmented as; Bacterial Skin Infections, Foodborne Infections, Sexually Transmitted Infections.
  • By Product: Based on the Product, Global Bacterial Disease Diagnostics Market is segmented as; Consumables, Instruments.
  • By End User: Based on the End User, Global Bacterial Disease Diagnostics Market is segmented as; Hospitals, Labs, Research Centres.
  • By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1. Research data source
    • 2.1.1. Secondary Data
    • 2.1.2. Primary Data
    • 2.1.3. SPER's internal database
    • 2.1.4. Premium insight from KOL's
  • 2.2. Market size estimation
    • 2.2.1. Top-down and Bottom-up approach
  • 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunities
    • 4.1.4. Challenges
  • 4.2. COVID-19 Impacts of the Global Bacterial Disease Diagnostics Market

5. Market variable and outlook

  • 5.1. SWOT Analysis
    • 5.1.1. Strengths
    • 5.1.2. Weaknesses
    • 5.1.3. Opportunities
    • 5.1.4. Threats
  • 5.2. PESTEL Analysis
    • 5.2.1. Political Landscape
    • 5.2.2. Economic Landscape
    • 5.2.3. Social Landscape
    • 5.2.4. Technological Landscape
    • 5.2.5. Environmental Landscape
    • 5.2.6. Legal Landscape
  • 5.3. PORTER's Five Forces
    • 5.3.1. Bargaining power of suppliers
    • 5.3.2. Bargaining power of buyers
    • 5.3.3. Threat of Substitute
    • 5.3.4. Threat of new entrant
    • 5.3.5. Competitive rivalry
  • 5.4. Heat Map Analysis

6. Competitive Landscape

  • 6.1. Global Bacterial Disease Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
  • 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Bacterial Disease Diagnostics Market

7. Global Bacterial Disease Diagnostics Market, By Type (USD Million)

  • 7.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Type, 2023-2033
  • 7.2. Bacterial Skin Infections
  • 7.3. Foodborne Infections
  • 7.4. Sexually Transmitted Infections

8. Global Bacterial Disease Diagnostics Market, By Product (USD Million)

  • 8.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Product, 2023-2033
  • 8.2. Consumables
  • 8.3. Instruments

9. Global Bacterial Disease Diagnostics Market, By Technology (USD Million)

  • 9.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By Technology, 2023-2033
  • 9.2. DNA Microarray
  • 9.3. Immunodiagnostics
  • 9.4. Isothermal Nucleic Acid Amplification Technology
  • 9.5. Polymerase Chain Reaction

10. Global Bacterial Disease Diagnostics Market, By End User (USD Million)

  • 10.1. Global Bacterial Disease Diagnostics Market Value Share and Forecast, By End User, 2023-2033
  • 10.2. Hospitals
  • 10.3. Labs
  • 10.4. Research Centres

11. Global Bacterial Disease Diagnostics Market Forecast, 2019-2033 (USD Million)

  • 11.1. Global Bacterial Disease Diagnostics Market Size and Market Share

12. Global Bacterial Disease Diagnostics Market, By Type, 2019-2033 (USD Million)

  • 12.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2019-2026)
  • 12.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Type (2027-2033)

13. Global Bacterial Disease Diagnostics Market, By Product, 2019-2033 (USD Million)

  • 13.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2019-2026)
  • 13.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Product (2027-2033)

14. Global Bacterial Disease Diagnostics Market, By Technology, 2019-2033 (USD Million)

  • 14.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2019-2026)
  • 14.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Technology (2027-2033)

15. Global Bacterial Disease Diagnostics Market, By End User, 2019-2033 (USD Million)

  • 15.1. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2019-2026)
  • 15.2. Global Bacterial Disease Diagnostics Market Size and Market Share By End User (2027-2033)

16. Global Bacterial Disease Diagnostics Market, By Region, 2019-2033 (USD Million)

  • 16.1. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2019-2026)
  • 16.2. Global Bacterial Disease Diagnostics Market Size and Market Share By Region (2027-2033)
  • 16.3. Asia-Pacific
    • 16.3.1. Australia
    • 16.3.2. China
    • 16.3.3. India
    • 16.3.4. Japan
    • 16.3.5. South Korea
    • 16.3.6. Rest of Asia-Pacific
  • 16.4. Europe
    • 16.4.1. France
    • 16.4.2. Germany
    • 16.4.3. Italy
    • 16.4.4. Spain
    • 16.4.5. United Kingdom
    • 16.4.6. Rest of Europe
  • 16.5. Middle East and Africa
    • 16.5.1. Kingdom of Saudi Arabia
    • 16.5.2. United Arab Emirates
    • 16.5.3. Rest of Middle East & Africa
  • 16.6. North America
    • 16.6.1. Canada
    • 16.6.2. Mexico
    • 16.6.3. United States
  • 16.7. Latin America
    • 16.7.1. Argentina
    • 16.7.2. Brazil
    • 16.7.3. Rest of Latin America

17. Company Profile

  • 17.1. Abbott Laboratories
    • 17.1.1. Company details
    • 17.1.2. Financial outlook
    • 17.1.3. Product summary
    • 17.1.4. Recent developments
  • 17.2. Accelerate Diagnostics Inc.
    • 17.2.1. Company details
    • 17.2.2. Financial outlook
    • 17.2.3. Product summary
    • 17.2.4. Recent developments
  • 17.3. Becton Dickinson and Co.
    • 17.3.1. Company details
    • 17.3.2. Financial outlook
    • 17.3.3. Product summary
    • 17.3.4. Recent developments
  • 17.4. Bio Rad Laboratories Inc.
    • 17.4.1. Company details
    • 17.4.2. Financial outlook
    • 17.4.3. Product summary
    • 17.4.4. Recent developments
  • 17.5. bioMerieux SA
    • 17.5.1. Company details
    • 17.5.2. Financial outlook
    • 17.5.3. Product summary
    • 17.5.4. Recent developments
  • 17.6. Bruker Corp.
    • 17.6.1. Company details
    • 17.6.2. Financial outlook
    • 17.6.3. Product summary
    • 17.6.4. Recent developments
  • 17.7. Danaher Corp
    • 17.7.1. Company details
    • 17.7.2. Financial outlook
    • 17.7.3. Product summary
    • 17.7.4. Recent developments
  • 17.8. DiaSorin SpA
    • 17.8.1. Company details
    • 17.8.2. Financial outlook
    • 17.8.3. Product summary
    • 17.8.4. Recent developments
  • 17.9. EKF Diagnostics Holdings Plc
    • 17.9.1. Company details
    • 17.9.2. Financial outlook
    • 17.9.3. Product summary
    • 17.9.4. Recent developments
  • 17.10. F. Hoffmann La Roche Ltd.
    • 17.10.1. Company details
    • 17.10.2. Financial outlook
    • 17.10.3. Product summary
    • 17.10.4. Recent developments
  • 17.11. GENERI BIOTECH s.r.o.
    • 17.11.1. Company details
    • 17.11.2. Financial outlook
    • 17.11.3. Product summary
    • 17.11.4. Recent developments
  • 17.12. Great Basin Scientific
    • 17.12.1. Company details
    • 17.12.2. Financial outlook
    • 17.12.3. Product summary
    • 17.12.4. Recent developments
  • 17.13. Hologic Inc.
    • 17.13.1. Company details
    • 17.13.2. Financial outlook
    • 17.13.3. Product summary
    • 17.13.4. Recent developments
  • 17.14. Meridian Bioscience Inc.
    • 17.14.1. Company details
    • 17.14.2. Financial outlook
    • 17.14.3. Product summary
    • 17.14.4. Recent developments
  • 17.15. Perkin Elmer Inc.
    • 17.15.1. Company details
    • 17.15.2. Financial outlook
    • 17.15.3. Product summary
    • 17.15.4. Recent developments
  • 17.16. QIAGEN NV
    • 17.16.1. Company details
    • 17.16.2. Financial outlook
    • 17.16.3. Product summary
    • 17.16.4. Recent developments
  • 17.17. Quest Diagnostics Inc.
    • 17.17.1. Company details
    • 17.17.2. Financial outlook
    • 17.17.3. Product summary
    • 17.17.4. Recent developments
  • 17.18. Siemens AG
    • 17.18.1. Company details
    • 17.18.2. Financial outlook
    • 17.18.3. Product summary
    • 17.18.4. Recent developments
  • 17.19. T2 Biosystems Inc.
    • 17.19.1. Company details
    • 17.19.2. Financial outlook
    • 17.19.3. Product summary
    • 17.19.4. Recent developments
  • 17.20. Takara Bio Inc.
    • 17.20.1. Company details
    • 17.20.2. Financial outlook
    • 17.20.3. Product summary
    • 17.20.4. Recent developments
  • 17.21. Others

18. List of Abbreviations

19. Reference Links

20. Conclusion

21. Research Scope